Sinphar Pharmaceutical Co Ltd (1734.TW) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · Taiwan · ISIN TW0001734002

Price
30.00 TWD
Market cap
6.41 bn TWD
P/E (2025)
–
P/S (2025)
1.90
Dividend yield
3.14 %
Net margin
10.85 %
Return on equity (ROE)
9.84 %
Return on assets (ROA)
5.94 %

Sinphar Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue3.15 bn TWD3.37 bn TWD
Gross profit1.24 bn TWD1.46 bn TWD
Operating income294.01 m TWD416.86 m TWD
EBIT343.87 m TWD435.37 m TWD
Net income304.71 m TWD365.75 m TWD

Full history since 2002, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Sinphar Pharmaceutical Co Ltd

Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.